Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Research|March 5, 2004
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cellsStefania Croci, Lorena Landuzzi, Annalisa Astolfi, et al.
Cancer Gene Therapy|March 16, 2002
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cellsKatia Scotlandi, Cecilia Maini, Maria Cristina Manara, et al.
Vaccine|May 17, 2011
HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccinesLorena Landuzzi, Agnese Antognoli, Giordano Nicoletti, et al.
Journal of Translational Medicine|June 3, 2014
Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cellsLaura Masuelli, Massimo Fantini, Monica Benvenuto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2004
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependentPatrizia Nanni, Lorena Landuzzi, Giordano Nicoletti, et al.
Journal of Cellular Physiology|August 23, 2018
Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancerLorenzo Castagnoli, Egidio Iorio, Matteo Dugo, et al.
The American Journal of Pathology|March 29, 2005
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinomaAnnalisa Astolfi, Lorena Landuzzi, Giordano Nicoletti, et al.
Cancer Research|November 17, 2007
Antimetastatic activity of a preventive cancer vaccinePatrizia Nanni, Giordano Nicoletti, Arianna Palladini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditionsKatia Scotlandi, Maria Cristina Manara, Rosaria Strammiello, et al.
Oncotarget|October 3, 2015
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastasesValerio Leoni, Valentina Gatta, Arianna Palladini, et al.
Pageof 8